A documented increase in medical cannabis authorizers and broad clinician support could reshape patient access and operator strategy. Here’s how DMV readers can think about it.

DEA’s 2026 Drugs of Abuse update says no deaths from marijuana overdose and reflects federal moves toward Schedule III for certain cannabis products. Here’s what it means in practice.

Weedmaps News flagged new coverage, but details are scarce. Here’s a DMV-first explainer to navigate cannabis delivery laws, licensing, and transport compliance without guessing.

Leafly’s October 2026 horoscopes spotlight a month shaped by planetary retrogrades with suggested strains. Here’s how DMV readers can use it wisely, from terpene tips to delivery compliance.

State Democrats say adult-use marijuana in Pennsylvania won’t move without control of both legislative chambers. Here’s what’s known, what isn’t, and why DMV readers should care.

Retailers moved $284.9M in cannabis across adult-use and medical in H1 2026 as Texas-border traffic buoyed New Mexico’s market. Here’s what it signals and why DMV readers should care.

NC paused a near‑ban on hemp THC beverages. Here’s what’s at stake for small businesses, delivery compliance, and how this debate echoes across the DMV.

Seasonal harvest sends cannabis hiring to its yearly peak. Here’s how Croptober planning impacts supply, delivery operations, and compliance for DMV consumers and couriers.

FBI-linked figures show more than 200,000 cannabis arrests in 2025—mostly for possession. Here’s what that means for DMV residents and why delivery compliance matters.

Four months after President Trump urged reclassification, DOJ made a partial move on cannabis scheduling. Here’s what it could mean for delivery laws and compliance.

A new Psychedelic Alpha podcast surveys D.C.’s psychedelic moment, the FDA’s evolving medical framework, and New Zealand’s MDMA prescribers—here’s why the DMV should care.

A small Johns Hopkins pilot gave two psilocybin doses to 20 adults with chronic Lyme symptoms. Participants reported improved sleep and quality of life, and a 40% symptom drop at six months.

From Indigenous leadership to hard truths about social media, here’s what stood out at Chacruna’s Psychedelic Culture 2026—and why Virginia residents should pay attention.

Under SB 3222, Illinois adult-use retailers can apply for medical cannabis licenses—opening the door to DEA eligibility and potential 280E relief, per MJBizDaily.

In a 7–0 decision, Nebraska’s high court left intact two 2024 initiatives approving medical cannabis and program rules, closing a challenge backed by top officials.

NORML reports, citing FBI data, that in six states marijuana accounts for the majority of drug-related arrests — highlighting stark differences in enforcement and compliance risks.

Clinical trial momentum has regulators eyeing MDMA and psilocybin. Here’s how “abuse potential” factors into rescheduling talks—and what DMV readers should watch.

Psychedelic Alpha reports that two psychiatrists in New Zealand have been cleared to prescribe MDMA for PTSD. Here’s what happened and what DMV readers should know.

New Cannabis Ventures reports Vireo is getting bigger but dropping to new lows. Here’s how to read that headline through a delivery laws and compliance lens in the DMV.

MJBizDaily reports the LEVIA THC beverage founders spent two years buying back their brand from MSO Ayr Wellness. Here’s what that ownership shift could signal for delivery compliance and business strategy.